Egypt, Feb. 4 -- The European Bank for Reconstruction and Development (EBRD) has fully exited its remaining 8.8 per cent stake in Ibnsina Pharma through the Egyptian Exchange (EGX).The Bank acquired a 20 per cent stake in Ibnsina Pharma in 2015 through a combination of primary and secondary transactions to finance the development of the company's warehouses, distribution centres and overall supply chain. Since then, the company has grown strongly, becoming the top pharma distributor in the Egyptian market and successfully expanding into a number of non-pharma operations. Ibnsina Pharma is an Egyptian joint stock company established in 2000 which specialises in the distribution of pharmaceutical products. The company is based in Cairo and op...